Jacobson Pharma Corporation Limited (HKG:2633)

HKG:2633 Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	509.05	411.94	1,036	478.65	480.35
Short-Term Investments	39.45	46.24	52.1	51.43	43.06
Cash & Short-Term Investments	548.49	458.17	1,089	530.08	523.41
Cash Growth	19.71%	-57.91%	105.35%	1.27%	5.52%
Accounts Receivable	145.09	172.83	288.23	308.94	260.99
Other Receivables	11.49	15.55	12.66	24.67	20.19
Receivables	156.58	188.39	300.89	333.61	281.19
Inventory	332.88	317.86	368	314.56	356.18
Total Current Assets	1,038	964.42	1,757	1,178	1,161
Property, Plant & Equipment	1,494	1,301	1,502	1,504	1,551
Long-Term Investments	449.38	481.51	569.77	471.03	519.86
Goodwill	183.72	183.72	450.57	444.26	444.26
Other Intangible Assets	174.45	187.54	805.1	805.19	851.93
Long-Term Deferred Tax Assets	10.23	10.85	10.23	10.16	10.26
Long-Term Deferred Charges	62.96	64.59	64.41	53.73	48.88
Other Long-Term Assets	232.37	292.8	220.87	289.16	280.57
Total Assets	3,645	3,487	5,380	4,756	4,867
Accounts Payable	41.66	51.69	80.25	50.46	38.59
Accrued Expenses	57.58	53.66	58.32	51.59	42.05
Current Portion of Long-Term Debt	237.2	112.8	309.55	612.18	685.91
Current Portion of Leases	24.01	26.87	34.82	33.97	35.94
Current Income Taxes Payable	33.2	16.7	28.41	20.83	14.33
Current Unearned Revenue	24.17	60.88	54.89	3.74	3.43
Other Current Liabilities	135.33	50.24	90.21	53.62	53.65
Total Current Liabilities	553.14	372.84	656.44	826.38	873.91
Long-Term Debt	476.5	592.2	1,234	729.47	892.21
Long-Term Leases	35.5	17.51	20.53	34.32	34.56
Long-Term Deferred Tax Liabilities	102.58	107.94	212.86	207.4	206.36
Total Liabilities	1,168	1,090	2,124	1,798	2,007
Common Stock	19.94	19.8	19.08	19.16	19.16
Additional Paid-In Capital	1,038	1,038	999.9	999.9	999.9
Retained Earnings	1,176	1,002	1,468	1,381	1,230
Comprehensive Income & Other	219.57	312.19	250.09	91.22	140.6
Total Common Equity	2,453	2,372	2,737	2,491	2,390
Minority Interest	24.22	24.22	519.83	466.65	470.26
Shareholders' Equity	2,477	2,396	3,257	2,958	2,860
Total Liabilities & Equity	3,645	3,487	5,380	4,756	4,867
Total Debt	773.21	749.38	1,599	1,410	1,649
Net Cash (Debt)	-224.72	-291.21	-510.54	-879.86	-1,125
Net Cash Per Share	-0.11	-0.15	-0.27	-0.46	-0.59
Filing Date Shares Outstanding	1,994	1,980	1,908	1,916	1,916
Total Common Shares Outstanding	1,994	1,980	1,908	1,916	1,916
Working Capital	484.81	591.57	1,101	351.86	286.88
Book Value Per Share	1.23	1.20	1.43	1.30	1.25
Tangible Book Value	2,095	2,001	1,481	1,242	1,094
Tangible Book Value Per Share	1.05	1.01	0.78	0.65	0.57
Land	1,214	1,152	127.43	103.06	102.34
Buildings	-	-	1,130	1,078	1,058
Machinery	937.91	908.37	1,018	1,002	973.99
Leasehold Improvements	127.22	40.63	42.25	45.58	36.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.